Mikhail Blagosklonny is a scientists focusing on cancer and aging. He studied at First Pavlov State Medical University of St. Peterburg where he earned both his M.D in internal medicine and also got his PHD in Cardiology and Experimental Medicine. He worked as the associate medicine professor at New York Medical College.
In 2002 he was appointed as senior scientist at Ordway Research Institute in New York. In 2009 he was appointed as the oncology professor at the New York Roswell Park Cancer Institute.
He is an associate editor to the Cancer Biology and Therapy, he is also chief editor of Oncotarget, cell cycle and aging he is involved in editorial board of Cell Death and Differentiation ,Autophagy, American journal of Pathology and PLOS ONE.
He is considered as one of the best advocates for rapamycin in aging research, this is because he formed a hypothesis about the possible role of TOR and its possible role in cancer and aging. This led to the proposed use of rapamycin which is a cancer treatment drug that is capable of extending ones’ life. He has also done a study on how to slow down aging and age-related diseases.
His research ranges from cellular biology and molecular to clinical investigation that includes anticancer therapeutics that stresses on translation of basic science into new anticancer strategies, cellular senescence and cell cycle.
According to Andrei V. Gudkov who is the Senior Vice- President of Basic Science at Roswell Park, says that Mikhail Blagosklonny is pre-eminent researcher who has developed unique concepts in cancer biology and therapy. The skills and experience he gathered from assorted places he worked at made him become a great professor.
Blagosklonny has published over 270 papers journals that are peer- reviewed with over 25,000 citations. He is the author of aging hyper function theory and cell cycle therapy engineering. He is confident that cancer and aging is controlable. His hard work and commitment in research is what has made him to become one of the known and respected Oncology researchers in the world. His mission is see a disease-free world. Visit classroomvoices.org to read more about Mikhail.